FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Weight Loss Drug Mounjaro to Be Launched in India in 2025; Know How It Tackles Obesity
Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
Alaska Dispatch News13hOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Pfizer Stopped Us From Getting Ozempic Decades Ago
In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...
Yahoo14h
Crews battle house fire in Jeannette
Crews battled a house fire Christmas morning in Jeannette. Our crew on scene saw firefighters responding to a house fire on N ...